Cargando…
Development of a Novel Anti-HIF-1α Screening System Coupled with Biochemical and Biological Validation for Rapidly Selecting Potent Anti-Cancer Compounds
Breast cancer (BCa) is the most diagnosed cancer and the second leading cause of cancer death in the American women. Adaptation to the hypoxic environment seen in solid tumors is critical for tumor cell survival and growth. The activation of hypoxia inducible factor-1 alpha (HIF-1α), an important ma...
Autores principales: | Lu, Yi, Madu, Chikezie, Masters, Jordan, Lu, Andrew, Li, Liyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026995/ https://www.ncbi.nlm.nih.gov/pubmed/24847382 http://dx.doi.org/10.7150/jca.9205 |
Ejemplares similares
-
Selection, Analysis and Improvement of Anti-Angiogenesis Compounds Identified by an Anti-HIF-1α Screening and Validation System
por: Madu, Chikezie, et al.
Publicado: (2016) -
Novel diagnostic biomarkers for prostate cancer
por: Madu, Chikezie O., et al.
Publicado: (2010) -
Nicotinamide–Ponatinib Analogues as Potent
Anti-CML and Anti-AML Compounds
por: Larocque, Elizabeth, et al.
Publicado: (2020) -
Epigenetic Modulators as Therapeutic Agents in Cancer
por: Patnaik, Eshaan, et al.
Publicado: (2023) -
Angiogenesis in Breast Cancer Progression, Diagnosis, and Treatment
por: Madu, Chikezie O., et al.
Publicado: (2020)